What regulated AI
must be able to show.
Operational analysis of AI governance, meaningful human oversight, security and sovereign deployment.
AI on the GMP Line: What the EU AI Act and Draft Annex 22 Now Ask You to Prove
Pharmaceutical AI must leave evidence that holds up under both horizontal AI rules and the more specific expectations of regulated manufacturing.
Sovereign AI in Qatar: Keeping the Evidence in the Country That Asked for It
Sovereignty is not only where an AI model runs. It is also where its decisions, oversight and audit evidence can be inspected.
ISO 42001 in Production: What the Auditor Actually Tests
An AI management system has to operate between audits. A certificate alone cannot explain what happened to one particular output.
Sovereign AI in the UAE: What You Have to Be Able to Prove
Regulated AI in the UAE must be governed in a way that fits the data, sector and jurisdiction in which it operates.
DIFC Regulation 10: what organisations must be able to show
DIFC Regulation 10 places operational obligations on autonomous and semi-autonomous systems that process personal data. The requirement reaches system use, intervention and explanation.
AI Governance in Qatar: What the Regulator Wants You to Show
A governance framework matters most when an institution can show how it affected a real AI decision.
What Defensible AI means in a regulated environment
A policy can show that an organisation intended to govern AI. Defensibility begins when one specific output can be reconstructed and explained under scrutiny.
AI in genomics and R&D: the evidence gap nobody talks about
A research choice made with AI today may need to be explained years later in a submission, diligence review or dispute.
Even the advisors need evidence. Especially the advisors.
Firms that advise others on AI controls need equally credible records for the AI used in their own work.
"The model is opaque" is not a defense. The regulator said so in writing.
A creditor cannot use a model's complexity to avoid explaining a consequential decision to the person affected.
The rubber stamp is not Human in the Loop
A review is not meaningful simply because a person clicked approve. The reviewer needs the context, competence and authority to change what happens next.
Pharmacovigilance is where AI evidence gets real.
Safety monitoring shows why an AI decision needs a traceable record, not only a plausible conclusion.
AI compliance in the GCC: the region that regulates by evidence.
Across the Gulf, regulated AI governance must be demonstrated through records that can be inspected in the relevant jurisdiction.
AI resilience isn't uptime. It's what you can prove after the incident.
Keeping a model available is only one part of resilience; an institution must also be able to reconstruct its decisions when something goes wrong.
Securing agentic AI before an output becomes an action
When AI can trigger transactions, permissions or workflow changes, a faulty output is no longer only a wrong answer. It can become an action executed at machine speed.
What evidence does the EU AI Act actually require for high-risk AI?
For high-risk AI, the Act's requirements connect risk management, event logs and effective human oversight to records that can be produced.
When clinical AI states a dose: enforcing the rule at the moment of output
A dose, code or diagnosis suggested by AI can enter a real workflow. The check must happen before that output is used.
Plausible isn't correct: enforcing pharmaceutical fact at runtime
In medicines, a polished AI answer can still contain a consequential error that must be caught before it is trusted.
Governing AI where it can't reach the internet
AI controls and their evidence must keep operating inside the security boundary, including when there is no external connection.